Aclaris Therapeutics
ACRS
ACRS
97 hedge funds and large institutions have $67.8M invested in Aclaris Therapeutics in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 27 increasing their positions, 39 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
31% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 39
33% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 27
Holders
97
Holding in Top 10
1
Calls
$76K
Puts
$94K
Top Buyers
| 1 | +$10.8M | |
| 2 | +$1.67M | |
| 3 | +$759K | |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$707K |
| 5 |
AI
Acuitas Investments
Seattle,
Washington
|
+$572K |
Top Sellers
| 1 | -$5.53M | |
| 2 | -$1.85M | |
| 3 | -$1.84M | |
| 4 |
Morgan Stanley
New York
|
-$1.81M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$1.13M |